Management of malignancy-associated hypercalcemia

Ralston S.H., Gallagher S.J., Patel U., Campbell J., Boyle I.T., Cancer-associated hypercalcemia: Morbidity and mortality. Clinical experience in 126 treated patients, Ann Intern Med, 112, pp. 499-504, (1990)

Vassilopoulou-Sellin R., Mewman B.M., Taylor S.H., Guinee V.F., Incidence of hypercalcaemia in patients with malignancy referred to a comprehensive cancer center, Cancer, 71, pp. 1309-1312, (1993)

Mundy G.R., Hypercalcemia of malignancy revisited, J Clin Invest, 82, pp. 1-6, (1988)

Martin T.J., Grill V., Hypercalcaemia in cancer, J Steroid Biochem Mol Biol, 43, pp. 123-129, (1992)

Watters J., Gerrand G., Dodwell D., The management of malignant hypercalcaemia, Drugs, 52, pp. 837-848, (1996)

Guise T.A., Mundy G.R., Cancer and Bone, Endocr Rev, 19, pp. 18-15, (1998)

Ralston S.H., Fogelman I., Gardiner M.D., Boyle I.T., Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcemia in malignancy, Br Med J, 288, pp. 1405-1408, (1984)

Harinck H.I.J., Bijvoet O.L.M., Plantingh A.S.T., Et al., Role of bone and kidney in tumor-induced hypercalcaemia and its treatment with bisphosphonate and sodium chloride, Am J Med, 82, pp. 1133-1142, (1987)

Bonjour J.P., Rizzoli R., Pathophysiological aspects and therapeutic approaches to tumoral osteolysis and hypercalcemia, Recent Results Cancer Res, 116, pp. 29-39, (1989)

Buchs B., Rizzoli R., Bonjour J.P., Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and non-malignant hypercalcemia, Bone, 12, pp. 47-56, (1991)

Ralston S.H., Gallagher S.J., Patel U., Campbell J., Boyle I.T., Cancer-associated hypercalcemia: Morbidity and mortality. Clinical experience in 126 treated patients, Ann Intern Med, 112, pp. 499-504, (1990)

Vassilopoulou-Sellin R., Mewman B.M., Taylor S.H., Guinee V.F., Incidence of hypercalcaemia in patients with malignancy referred to a comprehensive cancer center, Cancer, 71, pp. 1309-1312, (1993)

Mundy G.R., Hypercalcemia of malignancy revisited, J Clin Invest, 82, pp. 1-6, (1988)

Martin T.J., Grill V., Hypercalcaemia in cancer, J Steroid Biochem Mol Biol, 43, pp. 123-129, (1992)

Watters J., Gerrand G., Dodwell D., The management of malignant hypercalcaemia, Drugs, 52, pp. 837-848, (1996)

Guise T.A., Mundy G.R., Cancer and Bone, Endocr Rev, 19, pp. 18-15, (1998)

Ralston S.H., Fogelman I., Gardiner M.D., Boyle I.T., Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcemia in malignancy, Br Med J, 288, pp. 1405-1408, (1984)

Harinck H.I.J., Bijvoet O.L.M., Plantingh A.S.T., Et al., Role of bone and kidney in tumor-induced hypercalcaemia and its treatment with bisphosphonate and sodium chloride, Am J Med, 82, pp. 1133-1142, (1987)

Bonjour J.P., Rizzoli R., Pathophysiological aspects and therapeutic approaches to tumoral osteolysis and hypercalcemia, Recent Results Cancer Res, 116, pp. 29-39, (1989)

Buchs B., Rizzoli R., Bonjour J.P., Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and non-malignant hypercalcemia, Bone, 12, pp. 47-56, (1991)